VE-821 was the first specific and potent ATR inhibitor that abrogated G2/M checkpoint and reduced survival of various cancer cell lines after radiotherapy or treatment with chemotherapeutics including cisplatin, etoposide, gemcitabine, neocarzinostatin, and camptothecin [77,78,79,80,81,82,83]. This evidence concerns the gene ATR and cancer.